UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000015291 |
|---|---|
| Receipt number | R000017788 |
| Scientific Title | Frequency and characteristics of CD36 deficient patients among heart failure and cardiomyopathy |
| Date of disclosure of the study information | 2014/10/01 |
| Last modified on | 2015/10/03 13:23:51 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Frequency and characteristics of CD36 deficient patients among heart failure and cardiomyopathy
Acronym
Heart disease and CD36 deficiency
Scientific Title
Frequency and characteristics of CD36 deficient patients among heart failure and cardiomyopathy
Scientific Title:Acronym
Heart disease and CD36 deficiency
Region
| Japan |
Condition
Condition
heart failure, cardiomyopathy, CD36 deficiency
Classification by specialty
| Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To study frequency and characteristics of CD36 deficient patients among patients diagnosed with heart failure and cardiomyopathy
Basic objectives2
Others
Basic objectives -Others
pathophysiology, prospective observational study
Trial characteristics_1
Others
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
To study frequency of type I or type II CD36 deficient patients among patients diagnosed with heart failure and cardiomyopathy
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 85 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Hospitalized patients to treat heart failure or for close examination for cardiomyopathy
Key exclusion criteria
Patients with severe liver dysfunction
Patients with severe renal dysfunction
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Tatsuya Iso |
Organization
Gunma University Graduate School of Medicine
Division name
Education and Research Support Center
Zip code
Address
3-39-22 Showa-machi, Maebashi, Gunma
TEL
027-220-8145
isot@gunma-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Tatsuya Iso |
Organization
Gunma University Graduate School of Medicine
Division name
Education and Research Support Center
Zip code
Address
3-39-22 Showa-machi, Maebashi, Gunma
TEL
027-220-8145
Homepage URL
isot@gunma-u.ac.jp
Sponsor or person
Institute
Gunma University Graduate School of Medicine
Department of Cardiovascular Medicine
Institute
Department
Personal name
Funding Source
Organization
Gunma University Graduate School of Medicine
Department of Medicine and Biological Science
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 10 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2014 | Year | 09 | Month | 24 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 10 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We studied CD36 expression in platelet and monocyte in patients hospitalized for cardiac disease. We found type II deficiency in a patient among twenty we examined.
Management information
Registered date
| 2014 | Year | 09 | Month | 30 | Day |
Last modified on
| 2015 | Year | 10 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017788
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
